Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Open Access
- 15 October 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (8) , 2837-2843
- https://doi.org/10.4049/jimmunol.141.8.2837
Abstract
The in vitro killing of the human CEM cell line was studied by using ricin A-chain immunotoxins constructed with either the whole IgG or the Fab and F(ab')2 fragments of the same T101 (anti-CD5) antibody. In the presence of ammonium chloride as an activator, the "whole" immunotoxin as well as the "fragment" immunotoxins did not show any significant difference in the cell killing efficacy. In contrast, without the activator, the efficacy of the T101 immunotoxin was greatly improved when fragments were used. Indeed, at a saturating dose, a cytoreduction of three orders of magnitude was obtained with the fragment immunotoxins vs less than one order of magnitude for the whole immunotoxin, as assessed in a clonogenic assay. This enhancing effect was related to better cell killing kinetics, because with a similar amount of A-chain molecules bound per cell, T101 fragment immunotoxins achieved a twofold faster protein synthesis inactivation rate than the corresponding whole IgG immunotoxin. No significant difference in activity was shown between monovalent (Fab) and divalent (F(ab')2) forms of fragment immunotoxins. The observation that T101 fragment immunotoxins were more potent than intact immunotoxins was extended to another fragment immunotoxin constructed with an antibody (F111.98) directed against a different epitope of the CD5 Ag. In another model (anti-CD22 1G11 antibody on Raji cells), the fragment immunotoxin did not show any superiority over the IgG immunotoxin which was by itself very potent, strongly suggesting an Ag-dependent phenomenon.This publication has 20 references indexed in Scilit:
- Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal AntibodiesScience, 1983
- Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.Proceedings of the National Academy of Sciences, 1983
- Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma‐associated antigen p97International Journal of Cancer, 1982
- Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.Journal of Biological Chemistry, 1982
- MONOCLONAL ANTIBODY-RICIN A-CHAIN CONJUGATE SELECTIVELY CYTO-TOXIC FOR CELLS BEARING THE COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA ANTIGEN1982
- Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cellsNature, 1981
- Fc (IgG) receptor distributions in homogeneous and heterogeneous cell populations by flow microfluorometry.Proceedings of the National Academy of Sciences, 1981
- Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate.The Journal of Immunology, 1980
- Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.Proceedings of the National Academy of Sciences, 1980
- Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.The Journal of Immunology, 1980